Table 3 Perioperative outcomes based on the Wei-DSS.
Variable | Low-difficulty group (N = 47) | High-difficulty group (N = 57) | P |
---|---|---|---|
Operative time (min)a, b | 222.83 ± 119.03 | 318.14 ± 125.89 | <0.001 |
Intraoperative blood loss (ml)a, b | 320.85 ± 420.40 | 358.77 ± 344.23 | 0.191 |
Intraoperative blood transfusion | 13(27.7) | 34(59.6) | 0.001 |
Utilization of hepatic portal block | 17(36.2) | 16(28.1) | 0.404 |
Length of postoperative stay (days)b, c | 8(3–20) | 12(3–41) | 0.044 |
Morbidity of complications | 23(48.9) | 48(84.2) | <0.001 |
Clavien-Dindo I-II complication | 16(34.0) | 40(70.2) | <0.001 |
Clavien-Dindo III-IV complication | 7(14.9) | 8(14.0) | > 0.999 |
PHLF | 2(4.3) | 6(10.5) | 0.289 |
Bile leakage | 4(8.5) | 11(19.3) | 0.163 |
Pleural effusion | 18(38.3) | 34(59.6) | 0.048 |
Pneumonia | 7(14.9) | 14(24.6) | 0.326 |
R0 resection | 45(95.7) | 55(96.5) | > 0.999 |
Lymph node metastasis | 8(17.0) | 29(50.9) | <0.001 |
Tumor differentiation, moderate/poor | 44(93.6) | 57(100.0) | 0.178 |